{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-007463","form_type":"8-K","ticker":"BTCY","cik":"0001630113","company_name":"BIOTRICITY INC.","filed_at":"2022-03-22T23:59:59+00:00","discovered_at":"2026-05-14T18:04:07.457783+00:00","generated_at":"2026-06-26T21:00:38.544650+00:00","sec_items":["1.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Biotricity signs at-the-market offering agreement for up to $50 million common stock","bullets":["Enters ATM agreement with H.C. Wainwright to sell up to $50M of common stock from time to time.","Wainwright receives 3% commission on gross proceeds; Company reimburses up to $50K expenses.","Sales via 'at the market' offerings on Nasdaq; no obligation to sell any shares."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-007463","json":"https://secwatch.observer/filing/0001493152-22-007463.json","markdown":"https://secwatch.observer/filing/0001493152-22-007463.md","text":"https://secwatch.observer/filing/0001493152-22-007463.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1630113/000149315222007463/0001493152-22-007463-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1630113/000149315222007463/form8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T21:00:38.544650+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}